Your browser doesn't support javascript.
A definite case of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) induced by administration of the Pfizer/BioNTech BNT162b2 vaccine for SARS-CoV2.
Schroeder, Jan Walter; Gamba, Chiara; Toniato, Andrea; Rongioletti, Franco.
  • Schroeder JW; From the Unit of Allergology and Immunology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy, allergologia@ospedaleniguarda.it.
  • Gamba C; From the Unit of Allergology and Immunology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy, allergologia@ospedaleniguarda.it.
  • Toniato A; From the Unit of Allergology and Immunology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy, allergologia@ospedaleniguarda.it. Electronic address: andrea.toniato@ospedaleniguarda.it.
  • Rongioletti F; From the Dermatology Clinic, Vita-Salute S. Raffaele University, Milan, Italy.
Clin Dermatol ; 2022 May 10.
Article in English | MEDLINE | ID: covidwho-1944559
ABSTRACT
At the end of December 2020, the anti-SARS-CoV2 vaccination campaign began in Italy. As the number of vaccinated subjects in the general population has increased, several adverse reactions have been observed and reported. Severe cutaneous adverse reactions (SCARs) induced by drugs or vaccines are rare but distinguished by high mortality and include DRESS syndrome or drug induced hypersensitivity syndrome (DiHS), a condition characterized by skin rash, eosinophilia, fever, lymphadenopathy, and involvement of one or more internal organs. Here we present a definite case of DRESS that occured following the administration of Pfizer/BioNTech COVID 19 vaccine. He required hospitalization and was managed with supportive care, antihistamines, and intravenous steroid.

Full text: Available Collection: International databases Database: MEDLINE Topics: Vaccines Language: English Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Topics: Vaccines Language: English Year: 2022 Document Type: Article